Emergent BioSolutions Secures Exclusive U.S. Commercial Rights to Next Generation Pandemic Influenza Vaccine Candidate
Yahoo/BusinessWire
Emergent Biosolutions gains on earnings report
Marketwatch
Emergent BioSolutions Earnings Preview
Motley Fool
Sector Snap: Specialty drugs in 2012
BusinessWeek
Biotech Post-Holiday Regifting
Motley Fool

